NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- Simon Davies Discusses the Role of PD in Expanding Dialysis Acess Posted 05-15-2026
- Less Home Dialysis and Transplant in Pediatric Patients Transitioning to Adult Clinics Posted 05-15-2026
- World Conference in Nephrology Videos on Home Dialysis Posted 04-14-2026
- Vantive’s PD Catheter: Timing, Tips, and Techniques Webinar Posted 04-14-2026